Groundbreaking Israeli Study Shows How COVID Proteins Attack The Heart And Blood Vessels https://www.jpost.com/health-and-wellness/coronavirus/why-is-covid-causing-v... Earlier Thursday morning, we shared a report about a strange phenomenon unfolding at hospitals and emergency rooms across the US. Even as COVID cases continue to fall, emergency rooms across the country have become absolutely packed with patients seeking treatment for abdominal pain, blood clots, heart conditions and respiratory problems. All of these symptoms line up with the wide range of official COVID symptoms reported by the CDC. But, as the news reports state, the cause of this sudden wave, which has led to some patients being treated again in hospital hallways, remains officially unclear. More than 18 months after it first emerged from Wuhan, SARS-CoV-2, the virus that causes COVID, remains an enigma to scientists, who have been conducting a wide range of studies to try and learn more about how the virus does what it does. One of COVID's most notable features is its ability to cause damage not just to patient's respiratory system, but to the heart and vascular system as well. Oftentimes, this damage leaves patients with long-lasting symptoms that persist well beyond the initial infection. Even before it became the first nation on the planet to vaccinate nearly its entire population (it has been doling out booster jabs since August), Israel has been a leading source of COVID-related research. And the latest pioneering study produced by researchers from a range of disciplines (from epidemiology to computer science) at Tel Aviv University certainly raises some interesting questions, according to a report in the Jerusalem Post. The researchers have become the first on earth to identify which 5 of the 29 proteins that form the SARS-CoV-2 virus are responsible for damaging patients' blood vessels' ...[A] team of Tel Aviv University researchers have identified the five proteins of the 29 that form the virus which are responsible for damaging blood vessels. "We see a very high incidence of vascular disease and blood clotting, for example, stroke and heart attack among COVID patients," says Dr. Ben Maoz, lead author of the study published in the journal eLife. "We tend to think of COVID as primarily a respiratory disease but the truth is that coronavirus patients are up to three times more likely to have a stroke or heart attack,” he added. “All the evidence shows that the virus severely damages the blood vessels or the endothelial cells that line the blood vessels. However, to this day, the virus has been treated as one entity. We wanted to find out which proteins in the virus are responsible for this type of damage." The study was carried out using novel methods: researchers came together to insert different sequences of viral RNA into human blood vessels in a lab, and observed the reaction. In this manner, they were able to deduce which proteins caused the most damage to tissue from the vascular system. In particular, they found which proteins are responsible for doing the most damage to the human vascular system. "When the coronavirus enters the body, it begins to produce 29 proteins, a new virus is formed, then that virus produces 29 new proteins, and so on," Maoz said. "In this process, our blood vessels turn from opaque tubes into kind of permeable nets or pieces of cloth, and in parallel there is an increase in blood clotting. We thoroughly examined the effect of each of the 29 proteins expressed by the virus, and were successful in identifying the five specific proteins that cause the greatest damage to endothelial cells and hence to vascular stability and function." To help model and verify its findings, the team used computational models to discern exactly which proteins had the greatest impact on the human tissue. As the scientists said the hope is that this insight will help humanity develop a better understanding of how the virus causes so much damage to the heart and blood vessels. "Our research could help find targets for a drug that will be used to stop the virus’s activity, or at least minimize damage to blood vessels." But, what if it instead raises questions about the vaccines scientists have developed, which rely on viral RNA to "reprogram" the human immune system? Pfizer Vax Trial Being Probed After Whistleblower Exposes 'Falsified Data', According To Contractor https://www.theepochtimes.com/report-of-problems-with-pfizer-covid-19-vaccin... https://www.theepochtimes.com/approved-version-of-pfizers-covid-19-vaccine-s... https://redica.com/pharma-desk-inspections-missed-action-dates-take-place-of... The alleged problems with a major clinical trial examining Pfizer’s COVID-19 vaccine trial are being probed, a contract company involved in the research has confirmed. Ventavia Research Group operated several of the trial sites in the fall of 2020. Brook Jackson worked for the company during this time. She told the British Medical Journal (BMJ) that the trial was riddled with issues, including the falsification of data. Jackson said she alerted the Food and Drug Administration (FDA) to the problems she witnessed and was fired within hours of doing so. Ventavia confirmed to The Epoch Times that it employed Jackson for two weeks last year. Lauren Foreman, director of business development and communications, said in an email that Ventavia is investigating the allegations from Jackson. “Ventavia takes research compliance, data integrity, and participant safety very seriously and stands behind its important work supporting the development of lifesaving vaccines and is conducting its investigation accordingly,” she said. The FDA appeared to confirm it was aware of the matter. “Although the agency cannot comment further at this time in this ongoing matter, FDA has full confidence in the data that were used to support the Pfizer-BioNTech COVID-19 vaccine authorization and the Comirnaty approval,” a spokeswoman told The Epoch Times in an email. Ventavia worked on the trial that led to emergency use authorization (EUA) for Pfizer’s jab. The FDA later approved the shot, though many or all of the doses being administered in the United States continue to be the EUA-version. Pfizer did not immediately respond to a request for comment. Jackson, who worked with clinical trials for over 15 years, told the BMJ she repeatedly raised concerns with her superiors about what she was witnessing, including patient safety concerns. She began to feel her reports were being ignored and began taking photographs using her phone. One photograph apparently showed that needles were discarded in a plastic bag instead of a box, while another was said to have showed packaging materials that revealed trial participants’ identification numbers, signaling they may have been unblinded. Jackson listed 12 concerns she had in a Sept. 25 message to the FDA, including participants not being monitored after receiving an injection and vaccines not being stored at proper temperatures. She also alleged that Ventavia staff members were targeted by higher-ups for reporting problems. Jackson said the FDA sent her an email acknowledging receipt of the list and she received a call from an FDA inspector, but has heard nothing from the agency since then. The Epoch Times has submitted a Freedom of Information Act request concerning Jackson’s email to the FDA and internal communications from the agency regarding the message. The FDA said in August it inspected nine of the trial’s 153 sites. None of Ventavia’s sites were inspected. The inspections were limited “because the study was ongoing, and the data required for verification and comparison were not yet available to the IND [investigational new drug],” an FDA officer wrote in a summary of the inspections. Some pharmaceutical companies have seen inspections waived or FDA officials deciding to conduct an inspection remotely, Philip Crooker, technical vice president of Paraexel, told a forum in December 2020. Inspections of domestic sites plunged from 13,001 in 2019 to 6,574 in 2020, according to FDA data.